<code id='B6DFF8A79A'></code><style id='B6DFF8A79A'></style>
    • <acronym id='B6DFF8A79A'></acronym>
      <center id='B6DFF8A79A'><center id='B6DFF8A79A'><tfoot id='B6DFF8A79A'></tfoot></center><abbr id='B6DFF8A79A'><dir id='B6DFF8A79A'><tfoot id='B6DFF8A79A'></tfoot><noframes id='B6DFF8A79A'>

    • <optgroup id='B6DFF8A79A'><strike id='B6DFF8A79A'><sup id='B6DFF8A79A'></sup></strike><code id='B6DFF8A79A'></code></optgroup>
        1. <b id='B6DFF8A79A'><label id='B6DFF8A79A'><select id='B6DFF8A79A'><dt id='B6DFF8A79A'><span id='B6DFF8A79A'></span></dt></select></label></b><u id='B6DFF8A79A'></u>
          <i id='B6DFF8A79A'><strike id='B6DFF8A79A'><tt id='B6DFF8A79A'><pre id='B6DFF8A79A'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          leisure time

          author:fashion    - browse:4684
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus